Tag: Hatch-Waxman Act

Brand manufacturers produce their own generic versions to keep market share after patents expire. These authorized generics are identical to the original drug but sold under a different label. Learn how they're made, priced, and why they matter.

Brand companies launch authorized generics to protect revenue when patents expire. These are identical to the brand drug but sold cheaper, helping them keep market share while lowering prices for consumers.